CRISPR Gene-Editing Therapy Shows Durable One-Year Results in Lowering Cholesterol and Triglycerides
In a significant milestone for precision medicine, a first-in-human Phase 1 clinical trial conducted by the Cleveland Clinic has demonstrated that a single infusion of a CRISPR-Cas9 gene-editing therapy can…
